HK Stock Market Move | EASY SMART GP (02442) surged more than 36% again, with the stock price doubling in the past three trading days. The company announced the appointment of a new executive director.
Yijun Group Holdings (02442) saw its afternoon trading volume expand by more than 36%, with its stock price doubling over the past three trading days. As of the time of writing, it has risen 36.52%, trading at 3.14 Hong Kong dollars with a turnover of 2.3457 million Hong Kong dollars.
EASY SMART GP (02442) afternoon surge expanded by more than 36%, with the stock price doubling in the past three trading days. As of the time of writing, it rose by 36.52%, closing at HKD 3.14, with a turnover of HKD 2.3457 million.
On the news front, EASY SMART GP announced yesterday evening that Wang Jun has been appointed as an executive director of the company, effective from August 4, 2025. The announcement stated that Mr. Wang Jun is the President, Director, and controlling shareholder of Yubo International, a company listed on the US OTCQB market, holding 68.39% of the company's shares. Yubo Beijing is a biotechnology company specializing in storing endometrial stem cells as core technology, developing a series of products derived from human stem cells under the brand name "VIVICELL."
Public information shows that EASY SMART GP was listed on the Hong Kong Stock Exchange in May 2023. The company is a subcontractor specializing in passive fire engineering in Hong Kong, providing passive fire engineering services through its main operating subsidiaries (Yijun Engineering and Yijun Maintenance). As of the fiscal year ended June 30, 2022, the group ranked first in the Hong Kong passive fire engineering market in terms of revenue, with a market share of approximately 25.5%.
Related Articles

Renxin New Material (301395.SZ): The Huizhou Renxin New Material Phase III project has the conditions for trial production.

HK Stock Market Move | PRINX CHENGSHAN (01809) fell more than 7% in the final trading session, Thailand tire production base temporarily suspended production. The company stated that it is actively negotiating with the IEAT.

Humanwell Healthcare (600079.SH): HW241045 tablets approved for clinical trials of drugs.
Renxin New Material (301395.SZ): The Huizhou Renxin New Material Phase III project has the conditions for trial production.

HK Stock Market Move | PRINX CHENGSHAN (01809) fell more than 7% in the final trading session, Thailand tire production base temporarily suspended production. The company stated that it is actively negotiating with the IEAT.

Humanwell Healthcare (600079.SH): HW241045 tablets approved for clinical trials of drugs.

RECOMMEND

EU Defers Two Retaliatory Measures Against U.S. Tariffs by Six Months to Facilitate Trade Negotiations
05/08/2025

July Special Bond Issuance Reaches Year-to-Date Peak, Poised to Reinforce Infrastructure Investment
05/08/2025

Inbound Tourism Accelerates as China’s Travel Service Exports Jump Nearly 70% in H1
05/08/2025